Open menu Close menu Open Search Close search

Encora AM Tablets, Encora Capsules, Encora PM Tablets (Ther-Rx)

  • Description
  • Indications and Usage
  • Contraindications
  • Warnings
  • Precautions
  • Adverse Reactions
  • Dosage and Administration
  • How Supplied

    - Drugs index
    - Manufacturers
    - Feedback


    Encora™ is a prescription vitamin and mineral nutritional supplement with essential fatty acids consisting of two capsules and two tablets on each blister card designated for AM and PM oral administration as follows:

    AM tablet is an oval-shaped, light pink film-coated tablet containing the following ingredients:

    Calcium (calcium carbonate)400 mg

    Vitamin D 3 (cholecalciferol)200 IU

    Vitamin C (as Ester-C ® )25 mg

    Folic Acid, USP2 mg

    Vitamin B 6 (pyridoxine hydrochloride, USP)25 mg

    PM tablet is an oval-shaped, purple film-coated tablet containing the following ingredients:

    Calcium (calcium carbonate)600 mg

    Vitamin D 3 (cholecalciferol)600 IU

    Vitamin C (as Ester-C ® )25 mg

    Folic acid, USP0.5 mg

    Vitamin B 6 (pyridoxine hydrochloride, USP)12.5 mg

    AM and PM capsule is a pink soft gelatin capsule containing the following ingredients:

    Essential Fatty Acids (omega-3)650 mg

       DHA and EPA550 mg

       a - Linolenic acid (ALA)100 mg

    Linoleic acid (LA)10 mg

    Vitamin E (dl-alpha-tocopheryl acetate)50 IU

    Ester-C ® is a patented pharmaceutical grade material consisting of calcium ascorbate and calcium threonate.
    Ester-C ® is a licensed trademark of Zila Nutraceuticals, Inc.
    Eicosapentaenoic acid (EPA) to docosahexaenoic acid (DHA) ratio is approximately 2.7:1

    Inactive Ingredients :    Tablets: acacia, butylated hydroxyanisole, butylated hydroxytoluene, colloidal silicon dioxide, corn starch, croscarmellose sodium, D&C Red No. 27 aluminum lake, hydrolyzed gelatin, lecithin, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, sodium lauryl sulfate, stearic acid, sucrose, talc, titanium dioxide, and vegetable oil. The AM tablet also contains FD&C Blue No. 2 aluminum lake. The PM tablet also contains FD&C Blue No. 1 aluminum lake. Capsule: D&C Red No. 33, ethyl vanillin, FD&C Red No. 40, gelatin, glycerine, soybean oil and titanium dioxide.


    Encora™ is a patented formulation indicated to provide calcium, essential fatty acids, folic acid and other vitamins and minerals for daily nutritional and health supplementation.


    This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.


    Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B 12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive.

    Allergy Alert:    This product contains soy.



    Do not exceed recommended dosage. The calcium content should be considered before prescribing for patients with kidney stones. Encora™ should be used with caution in patients with known sensitivity or allergy to fish.

    Pediatric Use

    Safety and effectiveness in pediatric patients have not been established.

    Geriatric Use

    Clinical studies of this product did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, relfecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.


    Allergic sensitization has been reported following both oral and parenteral administration of folic acid.


    Encora™ is a morning and evening oral dosing regimen, supplied in unit-dose blister cards each containing an AM dose of 1 soft gelatin capsule and 1 light pink tablet and a PM dose of 1 soft gelatin capsule and 1 purple tablet.

    Encora™'s patented dosing regimen, consisting of an "AM" dose taken in the morning and a "PM" dose taken at night, should be followed for improved nutrient absorption potential, or as prescribed by your physician.


    Encora™ is supplied in a 30-day unit-of-use dispensing carton containing 30 blister cards of 2 tablets and 2 capsules each (NDC 64011-166-36).

    Encora™ AM tablets are oval-shaped, light pink film-coated tablets, embossed "Ther-Rx" on one side and "147" with a partial bisect on the other side. The PM tablet are oval-shaped, purple film-coated tablets, debossed "Ther-Rx" on one side and "161" with a partial bisect on the other side. Encora™ capsules are pink soft gelatin capsules, imprinted "Ther-Rx 148" on one side in purple ink.

    Store at controlled room temperature 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F). [See USP Controlled Room Temperature.] Avoid excessive heat above 40°C (104°F). Avoid freezing.


    Mktd. by Ther-Rx Corp., St. Louis, MO 63044

    U.S. Patent Nos. 4,822,816; 5,070,085; 5,945,123; 6,197,329; 6,214,379; 6,228,388; 6,258,846; 6,375,956; 6,576,666. Other U.S. Patents Pending.

    P4889    05/05

    - To bookmark this page (add it to your favorites), please click the image to the left.
    - If you wish to link to this page, you can do so by referring to the URL address below this line.

    This page was last modified 30-JUN-07
    Copyright © 1995-2021 ITA all rights reserved.